The authors present the results of a phase I/II clinical trial using autologous CD133+ bone marrow stem cell therapy to restore fertility in patients with Asherman Syndrome. The intervention was safe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback